Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW International, Inc. (“WW” or the “Company”).

Galloway believes WW is materially undervalued despite owning one of the world’s most recognized wellness brands and operating in the rapidly growing markets of weight management, metabolic health, GLP-1 support, and longevity.

Following its recent restructuring, WW reduced debt from approximately $1.4 billion to roughly $460 million while maintaining more than $220 million of cash on its balance sheet. Despite this improved capital structure, the Company’s market capitalization has fallen to less than $100 million.

“We believe the market is dramatically undervaluing WW’s brand, clinical business, member ecosystem, and long-term strategic potential,” said Bruce Galloway, Chief Investment Officer of Galloway Capital Partners.

Galloway noted that WW’s clinical business is growing more than 50% annually and believes the Company’s approximately 2.8 million members, combined with decades of proprietary consumer data, represent a highly valuable strategic asset in an increasingly personalized healthcare and wellness environment.

At current levels, WW trades at approximately 3.7x EBITDA, a substantial discount to peers in the digital health and wellness sector.

Galloway also stated that the Company has an opportunity to recruit a transformational CEO with expertise in consumer health, digital wellness, and subscription-based healthcare platforms.

“We believe WW is worth a multiple of its current trading value and look forward to engaging constructively with the Board and management team to help unlock shareholder value,” added Galloway.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260513227926/en/